Ipsen’s financial results for the first nine months of 2025

Ipsen’s financial results for the first nine months of 2025 will be published on 22 October 2025.

An investor and analyst conference call will follow at 1pm CET.

Ipsen Q3 Results Call

The investor and analyst conference call will take place on 22 October 2025 at 1pm CET. For the Q&A (audio only) please join here.

About Ipsen

We are a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience.

Our pipeline is fueled by internal and external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Our teams in more than 40 countries, and our partnerships around the world, enable us to bring medicines to patients in more than 100 countries.

Ipsen in brief

Discover Ipsen, our medicines and key figures, our objectives and our strategy.

Download Ipsen in brief

If you are experiencing difficulties registering for the investor and analyst conference call, please contact: khalid.deojee@ipsen.com

How useful was this post?

Click on a star to rate it!

Average rating 3.8 / 5. Vote count: 8

No votes so far! Be the first to rate this post.